News

Medicare price rule could hit Keytruda and Opdivo subcutaneous launches

Medicare · cancer · 5 min

FDA Approves Capivasertib for PTEN-Deficient Prostate Cancer

FDA · prostate cancer · 6 min

FDA approves belzutifan plus pembrolizumab for adjuvant RCC

FDA · renal cell carcinoma · 6 min

Prescription Drug Freight Fraud June 2026 report: what the record shows

EMA · 5 min

Planning a successful pivot from lab to clinic: a practical career map

4 min

HFMA conference: Affordability was the focus, but fixes remained unclear

4 min

FDA Draft Guidance Updates Payor Communications Rules

FDA · 4 min

Alembic Wins Tentative FDA Nod for First Generic Larotrectinib Capsules

FDA · NTRK fusion–positive solid tumors · 7 min

FDA Clears First OTC CGM for Children: Dexcom Expands Stelo

FDA · diabetes · 4 min

FDA priority review advances belzutifan plus pembrolizumab in adjuvant RCC

FDA · adjuvant renal cell carcinoma · 6 min

Chile warning labels on food: new evidence on efficacy and obesity risk

diabetes · 5 min

Socioeconomic status shapes children’s brain development, study finds

4 min